Pharmafile Logo

Glaucoma in perspective

BMS appoints Giovanni Caforio as chief commercial officer

Also hands Charles Bancroft an expanded brief

Roche - Basel

Roche cuts $1bn deal on cancer therapy with Immatics

Licenses series of early-stage oncology immunotherapy programmes

- PMLiVE

FDA clears J&J’s breakthrough lymphoma therapy

Imbruvica approved to treat mantle cell lymphoma

- PMLiVE

New head for UK PR Council

PRCA appoints Lansons Communications’ CEO Tony Langham

- PMLiVE

Eveo lands in London

Eveo's UK presence to be led by Cheslea Goodman

- PMLiVE

ISPE looks to Boehringer for new VP of Europe

Thomas Zimmer was senior VP at German pharma company

- PMLiVE

Text messages studied as tool for cutting type 2 diabetes risk

Imperial College London teams up with Rapide

ABPI London offices

ABPI pledges greater payment transparency

UK pharma trade body updates Code of Practice

- PMLiVE

Sarepta slumps as FDA questions muscular dystrophy drug

US regulator casts doubt on biomarker for eteplirsen

Hollingsworth leaves cancer charity for ABPI

Andrew Hollingsworth appointed policy manager at pharma industry body

- PMLiVE

New US guidelines to boost statin use but Crestor may miss out

American Heart Association and American College of Cardiology put emphasis on patient characteristics

Pfizer finally acquires the @pfizer name on Twitter

Will streamline its existing @pfizer_news account

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links